✦ LIBER ✦

PA24 CHOLESTYRAMINE THERAPY IS SAFE AND EFFECTIVE IN YOUNG PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

✍ Scribed by B. Malamisura; V. Bruno; M. Malamisura; G. Capano

Book ID: 119633558
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 90 KB
Volume: 41
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(09)60529-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy with statins is effective in som

Therapy with statins is effective in some patients with homozygous familial hypercholesterolemia

✍ V Tsimihodimos; G Miltiadous; M Elisaf 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Efficacy and safety of cholestyramine th

Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia

✍ Serena Tonstad; Jørgen Knudtzon; Mette Sivertsen; Helga Refsum; Leiv Ose 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 764 KB

The effect of combined fenofibrate and c

The effect of combined fenofibrate and cholestyramine therapy on low-density lipoprotein kinetics in familial hypercholesterolemia patients

✍ C.L. Malmendier; C. Delcroix; J-F. Lontie 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 423 KB

Statin therapy and risk of diabetes in p

Statin therapy and risk of diabetes in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia

✍ Skoumas, John; Liontou, Catherine; Chrysohoou, Christina; Masoura, Constantina; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 493 KB

Amsacrine is safe and effective therapy

Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia

✍ Zalmen A. Arlin; Eric J. Feldman; Abraham Mittelman; Tauseef Ahmed; Carmelo Pucc 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 2 views

The role of amsacrine in inducing remission in patients with cardiac disease and acute leukemia was evaluated. There were 17 patients with acute myelogenous leukemia (AML), six with acute lymphocytic leukemia (ALL), and one with biphenotypic leukemia. In this series of 24 patients whose disease had

Peg-interferon and ribavirin therapy is

Peg-interferon and ribavirin therapy is safe and effective among HCV patients with thalassaemia major

✍ D’Ambrosio, R.; Poggiali, E.; Mazzoleni, M.; Aghemo, A.; Lai, M.E.; Cianciulli, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 59 KB